Propelling: How Drones and 3D Mapping are Remodeling Building Design

 


Mapping is much different than it was even just a few years ago. Three-dimensional models are the new standard, improving upon the traditional two-dimensional renderings and blueprints.

Drones are a big part of this revolution and are giving everyone from architects to surveyors unprecedented access to landscapes, structures and worksites. Irene Kwan, Microdrones‘ Sales Manager for Southeast Asia, joined Propelling to explain how construction companies and municipalities are taking a new look at the way things have been done in the past.

“Traditionally for urban planning, it is carried out in two dimensions. So mostly, they have the experts there and they do the planning based on their feelings and their experience. But there is the problem, that we don’t actually know how accurate it is,” Kwan said.

Accuracy is important in any business decision but especially when mapping out entire city landscapes. Drones are providing this accuracy and, when coupled with technology like augmented reality, can give professionals complete immersion into a space. This level of precision is unprecedented and is opening new insights into the best use of land, materials and budgets.

In southeast Asia specifically, this accuracy can be lifesaving. Many areas in the region are prone to flooding and natural disaster, so it is crucial that public office holders have exact routes mapped out for citizens. Drones are helping to identify vulnerabilities in cities that would have previously gone unnoticed until was too late.

Listen to Kwan explain how three-dimensional modeling can be applied to urban sprawl, land development, virtual reality, emergency management and even some incredible Hollywood special effects.

For the latest news, videos, and podcasts in the AEC Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @AECMKSL
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More